Health and Me on MSN

India gets its first Alzheimer’s drug: Know all about Eli Lilly’s Lormalzi

The once-monthly therapy, administered as an intravenous infusion, targets amyloid plaques in the brain and may help slow ...
Reuters

Lilly Alzheimer's drug shows benefit on cognition, function in mid-stage trial

(Reuters) - Eli Lilly and Co on Saturday said its experimental Alzheimer’s drug slowed the rate of decline in a measure of cognition and function by 32% compared with a placebo in a mid-stage trial of ...

Eli-Lilly out with India’s first Alzheimer’s drug, Lormalzi

Eli-Lilly has launched India’s first disease-modifying Alzheimer’s drug, donenemab, under the brand name Lormalzi. Approved by the CDSCO in 2025, the treatment aims to slow cognitive decline in ...

HEALTH CANADA AUTHORIZES LILLY'S KISUNLA™ (DONANEMAB), A NEW TREATMENT FOR EARLY ALZHEIMER'S DISEASE

CNW/ - Today, after more than 35 years of commitment to advancing Alzheimer's research, Lilly Canada announced Health ...
Forbes India

India gets a booster shot for Alzheimer’s treatment

Eli Lilly’s new drug targets the pathophysiology of Alzheimer’s to slow progression of disease; price point and side effects ...
India Today on MSN

India gets first Alzheimer's drug amid debate over real benefits

Eli Lilly has launched Lormalzi, its donanemab treatment for early Alzheimer's disease, in India. The rollout opens a new ...
RAPS

Recon: Eli Lilly, AstraZeneca Scrap Two Alzheimer's Drug Trials

Regulatory Reconnaissance is our daily intelligence briefing for the regulatory affairs space, bringing you the top regulatory news stories from around the globe. Each weekday morning, we aim to bring ...